Desloratadine is a non-sedating, long-acting histamine antagonist with selective peripheral H1- receptor antagonist activity. After oral administration, desloratadine selectively blocks peripheral histamine H1- receptors because the substance is excluded from entry to the central nervous system.


Desloratadine 5 mg

Colour: Indigo Carmine and Titanium Dioxide

Excipients q.s.

Tades should be used with the following indications:

Indicated in adults and adolescents aged 12 years or older for the relief of symptoms associated with:

  • Allergic rhinitis;
  • Urticaria.

Oral use.

The dose can be taken with or without food.

Adults and adolescents (12 years of age and over): The recommended dose is one tablet once a day.

Intermittent allergic rhinitis (presence of symptoms for less than 4 days per week or for less than 4 weeks) should be managed in accordance with the evaluation of patient’s disease history and the treatment could be discontinued after symptoms are resolved and reinitiated upon their reappearance.

In persistent allergic rhinitis (presence of symptoms for 4 days or more per week and for more than 4 weeks), continued treatment may be proposed to the patients during the allergen exposure periods.